Last month, Bangladesh became the eighth country in the world to introduce the Typhoid Conjugate Vaccine (TCV). Nearly 50 million children from 9 months to 15 years will receive the vaccine as part of a campaign, after which the vaccine will be integrated into their routine immunisation programme. India is the major vaccine supplier for this drive, but is not one of the eight countries to have the typhoid vaccine in its routine immunisation schedule.

Health experts in Bangladesh have welcomed the move. Zakiur Rahman, professor at the Brahmanbaria Medical College, a microbiologist and consultant in family medicine, notes that not only is the burden of typhoid high in the country, the issue is complicated by difficulties in diagnosis and irrational treatments that contribute to increasing

See Full Page